Analyst Ratings for Milestone Pharmaceuticals (MIST)

MIST Rating Summary

MIST Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MIST
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.50 (+311.4%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/15/2025 TD Cowen Ritu Baral Upgrade Buy
(Hold)
8.00
(N/A)
2.41
(1.58)
-34.44% Details
9/11/2025 Wells Fargo
» Updated 12/16/2025
Mohit Bansal New Coverage Overweight
(N/A)
8.00
(4.00)
1.71
(1.58)
-7.6% Details